SALVADORI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 850
EU - Europa 631
AS - Asia 363
SA - Sud America 7
AF - Africa 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.863
Nazione #
US - Stati Uniti d'America 848
IT - Italia 270
SG - Singapore 173
IE - Irlanda 145
HK - Hong Kong 54
CN - Cina 43
KR - Corea 34
SE - Svezia 34
AT - Austria 25
DE - Germania 24
RO - Romania 20
FR - Francia 18
GB - Regno Unito 16
FI - Finlandia 15
RU - Federazione Russa 14
BE - Belgio 12
PH - Filippine 11
IN - India 9
NL - Olanda 9
CH - Svizzera 8
TR - Turchia 8
UA - Ucraina 8
BR - Brasile 6
VN - Vietnam 6
AU - Australia 5
EG - Egitto 5
JP - Giappone 5
IR - Iran 4
LB - Libano 4
PL - Polonia 4
TW - Taiwan 4
ES - Italia 3
CA - Canada 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
MY - Malesia 2
PK - Pakistan 2
UZ - Uzbekistan 2
CL - Cile 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
NO - Norvegia 1
TN - Tunisia 1
Totale 1.863
Città #
Chandler 191
Singapore 144
Dublin 142
Perugia 100
San Mateo 56
Santa Clara 53
Hong Kong 52
Boardman 50
Altamura 34
Ann Arbor 32
Redmond 31
Dearborn 28
Medford 28
Princeton 27
Vienna 24
Wilmington 22
Andover 20
Bucharest 19
Lawrence 18
Ashburn 17
Beijing 16
Brussels 12
Falls Church 11
Parma 9
Los Angeles 8
Cebu City 7
Redwood City 7
Seodaemun-gu 7
Collazzone 6
Des Moines 6
Glasgow 6
Norwalk 6
Saint Petersburg 6
Cairo 5
Dong Ket 5
Seoul 5
Helsinki 4
Karaj 4
Konya 4
Milan 4
Woodbridge 4
Xiamen 4
Amsterdam 3
Bologna 3
Cambridge 3
Delft 3
Dumaguete 3
Falkenstein 3
Hachenburg 3
Houston 3
Istanbul 3
Macerata 3
Mumbai 3
Perth 3
Rimini 3
São Paulo 3
Villeurbanne 3
Barrie 2
Bengaluru 2
Cannara 2
Chisinau 2
Cyberjaya 2
Didcot 2
Dongjak-gu 2
Ealing 2
Florence 2
Guangzhou 2
Jeju City 2
Jinan 2
Kinross 2
Kunming 2
Lugano 2
Mainz 2
Modena 2
Monreale 2
Moscow 2
Nam-gu 2
New York 2
Nürnberg 2
Olomouc 2
Oneonta 2
Phoenix 2
Piemonte 2
Raisio 2
Seongnam-si 2
Sindelfingen 2
Suwon 2
Taipei 2
Turin 2
Turku 2
Valenciennes 2
Wollongong 2
Yuseong-gu 2
Alviano 1
Ancona 1
Assisi 1
Bergen 1
Capannelle 1
Changsha 1
Chicago 1
Totale 1.358
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 119
RAGE in the pathophysiology of skeletal muscle. 100
Histological muscle characterization in hypertrophied Marchigiana cattle breed 94
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 91
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 89
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 77
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 76
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 72
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 71
Natural products to counteract muscle atrophy 69
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 67
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 65
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 64
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 62
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 61
The receptor RAGE: a potential molecular target in cancer cachexia 58
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 57
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 57
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 55
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 53
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 48
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 45
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 45
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 44
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 43
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 39
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 36
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 31
Equisetum arvense standardized extract hinders age-related sarcopenia 31
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 27
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 25
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 25
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 24
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 16
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 15
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 12
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 9
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 9
Totale 1.981
Categoria #
all - tutte 8.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 9 21 19 3 56 16 1 1
2020/2021155 1 4 10 4 62 21 24 2 10 8 3 6
2021/2022290 3 40 9 17 6 8 8 75 10 32 43 39
2022/2023548 30 104 3 49 44 61 1 25 198 2 22 9
2023/2024286 15 23 5 23 8 21 80 4 4 14 22 67
2024/2025428 43 83 134 70 98 0 0 0 0 0 0 0
Totale 1.981